ARCAPTA NEOHALER is a Oral; Respiratory (inhalation) Capsule in the Human Prescription Drug category. It is labeled and distributed by Sunovion Pharmaceuticals Inc.. The primary component is Indacaterol Maleate.
Product ID | 63402-675_1250b6c5-cdae-4771-ae60-1463c97cecca |
NDC | 63402-675 |
Product Type | Human Prescription Drug |
Proprietary Name | ARCAPTA NEOHALER |
Generic Name | Indacaterol Maleate |
Dosage Form | Capsule |
Route of Administration | ORAL; RESPIRATORY (INHALATION) |
Marketing Start Date | 2011-07-01 |
Marketing End Date | 2021-01-31 |
Marketing Category | NDA / NDA |
Application Number | NDA022383 |
Labeler Name | Sunovion Pharmaceuticals Inc. |
Substance Name | INDACATEROL MALEATE |
Active Ingredient Strength | 75 ug/1 |
Pharm Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
NDC Exclude Flag | N |
Marketing Start Date | 2017-06-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022383 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-07-01 |
Marketing End Date | 2021-01-31 |
Marketing Category | NDA |
Application Number | NDA022383 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-06-01 |
Marketing End Date | 2021-01-31 |
Marketing Category | NDA |
Application Number | NDA022383 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2011-07-01 |
Marketing End Date | 2021-01-31 |
Marketing Category | NDA |
Application Number | NDA022383 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-06-01 |
Marketing End Date | 2021-01-31 |
Ingredient | Strength |
---|---|
INDACATEROL MALEATE | 75 ug/1 |
SPL SET ID: | e82416ba-23b9-4d40-a41d-baba8e11751b |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |